Mardi Dier, EVP and CFO at MADRIGAL PHARMACEUTICALS, INC. (MDGL), sold 2,958 shares at $431.94 ($1.3M) on 2026-03-06, disclosed to the SEC on 2026-03-06.
Open-market sale of $1.3M MDGL by EVP and CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $425.08 | 40 | $17K | 1.3% |
| 2 | $426.86 | 420 | $179K | 14.1% |
| 3 | $426.86 | 420 | $179K | 14.1% |
| 4 | $427.85 | 80 | $34K | 2.7% |
| 5 | $427.85 | 80 | $34K | 2.7% |
| 6 | $429.00 | 160 |
| $69K |
| 5.4% |
| 7 | $429.00 | 160 | $69K | 5.4% |
| 8 | $429.58 | 40 | $17K | 1.3% |
| 9 | $430.90 | 120 | $52K | 4.1% |
| 10 | $430.90 | 120 | $52K | 4.1% |
| 11 | $431.94 | 646 | $279K | 21.9% |
| 12 | $432.56 | 116 | $50K | 3.9% |
| 13 | $432.56 | 116 | $50K | 3.9% |
| 14 | $434.20 | 160 | $69K | 5.5% |
| 15 | $435.31 | 80 | $35K | 2.7% |
| 16 | $435.32 | 80 | $35K | 2.7% |
| 17 | $436.69 | 80 | $35K | 2.7% |
| 18 | $437.65 | 40 | $18K | 1.4% |
| Total | $430.31 avg | 2,958 | $1.3M | 100% |
| Filing → |
| MDGL | SELL | 2025-03-12 | $167K | — | Filing → |
| MDGL | SELL | 2025-03-05 | $1.3M | — | Filing → |
| SLRN | BUY | 2023-05-11 | $116K | — | Filing → |